Balanced news tone
News Sentiment
PTN sentiment intelligence
Palatin Technologies, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
71 relevant articles
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-9.1% over one week, -22.4% over four weeks, trend inactive, and below fair value.
Palatin stock trades quietly as revenue stabilizes after FY 2025 loss
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
79/100 classification
One-week reaction
-9.1%
Price reacting lower
Trend fit
Trend inactive
-22.4% over four weeks
Fair value
-47.7%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
12
Neutral
54
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Ad-hoc-news.de
Direct company coverage
Palatin stock trades quietly as revenue stabilizes after FY 2025 loss
Palatin Technologies (PTN) stock is trading quietly after reporting stabilized revenue and a narrowed net loss for fiscal year 2025. The biotech company saw its total revenue increase to $16.3 million from $10.4 million in FY 2024, primarily driven by sales of its lead product Vy
- Tone
- Positive 67/100
- Event
- Earnings
- Published
- 21 Jul 2026 14:35
- Source
- Ad-hoc-news.de
Stock Titan
Direct company coverage
Palatin Technologies (PTN) CEO has 294 shares withheld for taxes
Carl Spana, President and CEO of Palatin Technologies (PTN), reported three F-code transactions on July 15, 2026, involving the withholding of 294 common shares by the issuer. These shares, valued at $14.34, $11.72, and $11.77 per share, were used to satisfy employee withholding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 20:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
Palatin Technologies (PTN) CFO has 195 shares withheld for taxes
Palatin Technologies' Executive VP and CFO/COO, Stephen T. Wills, had 195 shares of common stock withheld for tax-withholding dispositions on July 15, 2026. These shares were withheld to cover employee withholding taxes on recently vested equity grants, with per-share values rang
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 20:39
- Source
- Stock Titan
Market source
Industry context
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
Market source
Industry context
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
AD HOC NEWS
Direct company coverage
Palatin Technologies explores drug pipeline as investors track Nasdaq listing
Palatin Technologies, a biotech company specializing in melanocortin receptor therapies, is advancing its drug pipeline, with a focus on areas like sexual dysfunction, inflammatory diseases, and metabolic disorders. Its shares trade on Nasdaq, and investors are keenly watching fu
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 17:50
- Source
- AD HOC NEWS
TradingView
Direct company coverage
Price to cash flow ratio of Palatin Technologies, Inc. – NASDAQ:PTN
This article provides the price to cash flow ratio for Palatin Technologies, Inc. (NASDAQ: PTN). It lists the period, value, and change metrics for this financial indicator but does not include the actual numerical values. The content is presented as part of a financial data over
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 07 Jul 2026 22:41
- Source
- TradingView
TradingView
Direct company coverage
Tangible book value per share of Palatin Technologies, Inc. – NASDAQ:PTN
The article focuses on the tangible book value per share of Palatin Technologies, Inc. (NASDAQ: PTN), providing a financial overview of the company through TradingView. It highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. The
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 04:11
- Source
- TradingView
timothysykes.com
Direct company coverage
Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Jul 2026 07:00
- Source
- timothysykes.com
TradingView
Direct company coverage
A41E9H Forecast — Price Target — Prediction for 2027
This article provides a forecast for Palatin Technologies, Inc. (A41E9H) stock, including analyst price targets and future earnings estimates. It details the company's past earnings and revenue performance, upcoming earnings report date, and confirms that A41E9H does not pay divi
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Jul 2026 06:09
- Source
- TradingView
TradingView
Direct company coverage
Palatin Technologies, Inc. Actuals & Estimates (LSX:A41E9H)
This article provides financial actuals and estimates for Palatin Technologies, Inc. (LSX:A41E9H), including income statement, balance sheet, and cash flow data. It also covers analyst forecasts, earnings reports, and key financial metrics like revenue, net income, and dividend p
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 02 Jul 2026 19:39
- Source
- TradingView
TradingView
Direct company coverage
Why Tenet Healthcare (THC) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- TradingView
www.marketscreener.com
Direct company coverage
Palatin Technologies, Inc.(NasdaqCM:PTN) added to Russell Microcap Growth Benchmark Index
Palatin Technologies, Inc. (NasdaqCM:PTN) has been added to the Russell Microcap Growth Benchmark Index, as announced on June 28, 2026. This inclusion highlights the biopharmaceutical company's growth and increased visibility within the market, following recent additions to other
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 29 Jun 2026 17:40
- Source
- www.marketscreener.com
TradingView
Direct company coverage
Enterprise value to EBIT forward of Palatin Technologies, Inc. – NASDAQ:PTN
This article provides the enterprise value to EBIT forward for Palatin Technologies, Inc. (NASDAQ: PTN). The content is a snippet from a financial data platform, likely TradingView, focusing on the company's financial overview. It does not provide any detailed analysis or specifi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 08:40
- Source
- TradingView
TradingView
Direct company coverage
Palatin Technologies, Inc. Actuals & Estimates (LS:A41E9H)
This article provides an overview of Palatin Technologies, Inc. (A41E9H) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It details recent earnings, revenue, and net income figures, and shares analyst forecasts for future stock pric
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 20:39
- Source
- TradingView
TradingView
Direct company coverage
Enterprise value to revenue forward of Palatin Technologies, Inc. – NASDAQ:PTN
This article briefly highlights the "Enterprise value to revenue forward" metric for Palatin Technologies, Inc. (NASDAQ: PTN). The content appears to be a financial data snippet from TradingView, indicating a specific period and value for this metric, without providing further an
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 20:39
- Source
- TradingView
TradingView
Direct company coverage
Palatin Technologies, Inc. Actuals & Estimates (NASDAQ:PTN)
This article provides an overview of Palatin Technologies, Inc. (NASDAQ: PTN) stock, including financial data, analyst estimates, and price performance. It covers current stock price movements, historical highs and lows, market capitalization, and upcoming earnings report dates.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 15:08
- Source
- TradingView
TradingView
Direct company coverage
Price to book forward of Palatin Technologies, Inc. – NASDAQ:PTN
This article provides the "Price to book forward" value for Palatin Technologies, Inc. (NASDAQ:PTN). It indicates that the market was closed at the time of publication and there were no trades. The core content focuses solely on this specific financial metric for PTN.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 11:39
- Source
- TradingView
TradingView
Direct company coverage
Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters
Rhythm Pharmaceuticals' recent positive Phase 2 data for setmelanotide in Prader-Willi syndrome strengthens the therapeutic thesis for activating the melanocortin-4 receptor (MC4R). This validation benefits smaller competitor Palatin Technologies, which is developing next-generat
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 19 Jun 2026 20:10
- Source
- TradingView
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Palatin Technologies Inc (PTN), highlighting its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between a resistance level of 14.05 and a sup
- Tone
- Negative 19/100
- Event
- Market update
- Published
- 19 Jun 2026 00:39
- Source
- TradingKey
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates
Palatin Technologies Inc (PTN) has an earnings forecast score of 8.00, placing it highly within the Biotechnology & Medical Research industry. Analysts provide a strong buy rating with an average price target of $51.50, indicating significant upside potential. The company's expec
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 19 Jun 2026 00:39
- Source
- TradingKey
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Institutional Confidence
Palatin Technologies Inc (PTN) has an institutional shareholding score of 3.00, placing it 193rd out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 5.52%, marking an 89.11% decrease quarter-over-quarter. Steven Cohen i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 00:39
- Source
- TradingKey
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Valuation: PE, PB & Fair Value Analysis
This article provides a company valuation for Palatin Technologies Inc (PTN), noting that no specific valuation score is currently available. It highlights the company's P/E ratio of 107.30 and compares it to recent highs and lows, as well as the industry average in Biotechnology
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 21:39
- Source
- TradingKey
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Palatin Technologies Inc (PTN), listing its major institutional and individual shareholders. It provides a breakdown of shareholder types, including investment advisors, hedge funds, and venture capitalists, along with institution
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 08:18
- Source
- TradingKey
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Palatin Technologies Inc (PTN) regarding its dividend history and stock splits. It states that PTN has not distributed any dividends over the past five years and details multiple 25-to-1 merger-related stock splits on August 22, 2022. The page
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 07:39
- Source
- TradingKey
TradingKey
Direct company coverage
Palatin Technologies Inc (PTN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey concerns Palatin Technologies Inc (PTN) and aims to provide a breakdown of its revenue by business segments and regions. However, the article states that the relevant data for these breakdowns have not been disclosed by the company yet. It primarily s
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 05:18
- Source
- TradingKey
Market source
Direct company coverage
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
TradingView
Direct company coverage
Palatin Technologies, Inc. Cash Flow – NASDAQ:PTN
Palatin Technologies, Inc. (NASDAQ:PTN) reported a free cash flow of -4.46 million USD for Q3 2026. For the full year 2025, the company's free cash flow and operating cash flow were both -21.31 million USD. This data provides insight into the company's financial performance relat
- Tone
- Negative 39/100
- Event
- Balance sheet
- Published
- 11 Jun 2026 01:11
- Source
- TradingView
TradingView
Direct company coverage
Book value per share of Palatin Technologies, Inc. – NASDAQ:PTN
The article focuses on the book value per share of Palatin Technologies, Inc. (NASDAQ: PTN). It appears to be a financial data presentation that likely shows the period value and changes related to the company's book value per share. The content is primarily a structural page fro
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 20:40
- Source
- TradingView